Variables | Groups | p | |||
---|---|---|---|---|---|
G1 (Phakic + gas) (n = 46) | G2 (Pseudophakic + gas) (n = 43) | G3(Phakic + SO) (n = 13) | G4 (Pseudophakic + SO) (n = 15) | ||
Male gender (n,%) | 25/46 (54.7%) | 32/43 (74.4%) | 8/13 (61.5%) | 12/15 (80.0%) | 0.14a |
Age (mean ± SD) | 58.5 ± 13.5 | 62.7 ± 10.2 | 51.6 ± 17.8 | 70.7 ± 9.5 | 0.001c* |
Duration of symptoms (days) (median, range) | 7 (0–185) | 7 (1–256) | 7 (1–730) | 6 (0–230) | 0.9d |
Preop BCVA (in logMAR) (median, range) | 1.5 (0.05–3) | 0.52 (0–3) | 2 (0–3) | 3 (0.2–3) | 0.03d* |
Preoperative PVR (n, %) | 11/46 (23.9%) | 4/43 (9.3%) | 5/13 (38.5%) | 6/15 (40.0%) | 0.03a* |
Reattachment rate (n,%) | 100% (46/46) | 95.3% (41/43) | 76.9% (10/13) | 86.7% (13/15) | 0.011b* |
Preoperative IOP (mean ± SD, range) | 14.8 ± 4.7 (0–26) | 14.2 ± 4.7 (5–24) | 14.7 ± 3.2 (10–21) | 10.9 ± 5.9 (0–21) | 0.064c |
Postoperative IOP (mean ± SD, range) | 16.1 ± 4.0 (10–27) | 14.8 ± 3.2 (9–25) | 16.5 ± 7.0 (4–27) | 13.8 ± 3.3 (9–19) | 0.152c |